Metrics as of 10/17/2026, 07:38 AM (Berlin time), refresh in progress.
Waters Stock
Waters Corporation
Company data
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- Country
- United States
- CEO
- Udit Batra
- Employees
- 7,900
- Market cap
- $42.9 B
- IPO
- 17/11/1995
Waters Corporation is a global leader in specialized measurement, providing analytical solutions across Asia, the Americas, and Europe. Established in 1958, the company is headquartered in Milford and operates within the Healthcare sector. The business is organized into two main divisions, namely the Waters segment…
Company description based on the data provider's company data, AI-assisted, created on 16/10/2026. Not investment advice.
Waters stock: price history
1D
-1.6%
1W
+0.7%
1M
+4.4%
6M
+33.3%
YTD
+15.0%
1Y
+30.5%
2Y
+23.4%
5Y
+26.8%
10Y
+182.1%
Next earnings date
Next earnings date
03/11/2026 (in 17 days)
Volatility around earnings
~70% stronger price swings than usual
Waters stock scores
- Valuation
Visible after free registration
- Trend
Visible after free registration
- Quality
Visible after free registration
- Dividend
Visible after free registration
- Growth
Visible after free registration
- Insider
Visible after free registration
- Earnings
Visible after free registration
- Revisions
Visible after free registration
- Sentiment
Visible after free registration
- Short Pressure
Visible after free registration
Register for free
Unlock all 11 scores
- 5 credits free on registration
- Access to virtual portfolios and watchlist
- No credit card, no payment details needed
- No subscription, no minimum term
- Our own servers in Germany, no US cloud
Deterministically calculated from financial metrics, not investment advice. Updated nightly, last on 17/10/2026.
Business model & megatrends
Average business model without a clear megatrend link or with mixed signals.
3 more assignments (Enabler/Second row) Pro-only.
Waters Corporation is a global provider of specialized measurement solutions for chemical, pharmaceutical, and biotechnology research as well as quality control. The business model combines the sale of highly complex precision instruments, such as chromatography and mass spectrometry systems, with a strong focus on recurring revenues. These are generated through the distribution of essential consumables, specialized software, and comprehensive maintenance and service offerings. The technological complexity and integration of the products into critical processes such as drug development or environmental analysis create high customer loyalty among users in the life sciences, pharma, and industrial sectors. Through the interplay of hardware, software, and consumables, the company is firmly embedded in the research and production workflows of its customer base.
- Revenue model
- Mixed
- Recurring revenue
- High
- Pricing power
- Weak
- Moat
- None
- Moat type
- None
- Capital intensity
- High
- Customer concentration
- Unknown
Ask the agents about Waters
Analyst assessment of Waters
PRICE TARGET LOW
US$387.00
CONSENSUS
US$453.50
MEDIAN
US$455.00
PRICE TARGET HIGH
US$515.00
0
STRONG BUY
19
BUY
16
HOLD
2
SELL
0
STRONG SELL
37
TOTAL · Buy
As of: 13/10/2026
Waters stock metrics
P/E
108.69
P/B
2.82
EV/EBITDA
50.08
RETURN ON EQUITY
-0.9%
NET MARGIN
-8.3%
DEBT/EQUITY
0.35
DIVIDEND YIELD
0.0%
AS OF
04/07/2026
Free float & liquidity
FREE FLOAT
99.9%
FLOAT SHARES
98,065,370
AVG. DAILY VOLUME (30D)
798,178
Insider transactions (SEC)
Jiang Wei
Knight Heather
KUEBLER CHRISTOPHER A
KUEBLER CHRISTOPHER A
Jiang Wei
Attention
1 mention today in US forums, about the same as yesterdayPrice since yesterday: -1.6%
Forums (Reddit)
Institutional holders
Dividends & Stock splits
Dividends
Stock splits
Smart Money
Register for free
Register now to see which funds are invested
- 5 credits free on registration
- Access to virtual portfolios and watchlist
- No credit card, no payment details needed
- No subscription, no minimum term
- Our own servers in Germany, no US cloud
Comparable stocks
Frequently asked questions about Waters stock
What does Waters do?
Waters Corporation is a company in the Healthcare sector, Medical - Diagnostics & Research industry, headquartered in United States.
The CEO is Udit Batra, the company employs around 7,900 people.
The IPO was on 17/11/1995; the stock trades on NYSE under the ticker WAT.
What do analysts say about Waters stock?
37 analysts rate the stock, the consensus is Buy (as of 13/10/2026).
The average price target is US$453.50, ranging from US$387.00 to US$515.00, with a median of US$455.00.
This is an external assessment, not a statement by Market Jury.
When does Waters report next?
The next earnings date is 03/11/2026.
Around past earnings, price swings were roughly 70% stronger than usual.
Does Waters pay a dividend?
Yes. The last dividend was US$0.16 per share.
The dividend yield is 0.0% (as of 04/07/2026).
Which stocks are comparable to Waters?
Comparable stocks include Thermo Fisher Scientific, Danaher, Natera, Agilent Technologies, IQVIA Holdings, Illumina, IDEXX Laboratories and Mettler-Toledo International.
How can I get Waters stock analyzed?
Clicking "Analyze stock" lets five strategies assess Waters against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.